Suppr超能文献

用藻酸盐微球递送系统对兔进行多杀性巴氏杆菌的口服免疫。

Oral immunization of rabbits against Pasteurella multocida with an alginate microsphere delivery system.

作者信息

Suckow M A, Bowersock T L, Park H, Park K

机构信息

Laboratory Animal Program, Purdue University, West Lafayette, IN 47907, USA.

出版信息

J Biomater Sci Polym Ed. 1996;8(2):131-9. doi: 10.1163/156856296x00200.

Abstract

Oral delivery of microencapsulated antigens is a potential means to vaccinate rabbits against Pasteurella multocida, a common bacterial pathogen. Groups of five rabbits were dosed orally on days 0, 7, and 14 with alginate microspheres prepared to contain no added protein, 5 mg of a potassium thiocyanate extract of P. multocida (PTE), or 5 mg of PTE with 200 micrograms of cholera toxin (CT). In addition, groups were dosed orally with 5 mg of soluble PTE with or without 200 micrograms CT, intranasally (IN) with 1 mg of soluble PTE, or with saline. Serum and nasal lavage samples collected prior to initial immunization and 10, 16, and 21 days later were assayed by ELISA for anti-PTE IgG and IgA. Strong nasal lavage IgA and serum IgG activities were found in samples from rabbits immunized with PTE IN or orally when incorporated into microspheres. Addition of CT did not significantly enhance either response. To examine the development of protective immunity, groups were similarly immunized and challenge-exposed IN on day 16 with 10(6) CFU of P. multocida. One week later, rabbits were euthanized, and specimens from the lungs, nasopharynx, liver, and inner ear were cultured for P. multocida. Less severe infections of the lung and nasopharynx developed in rabbits immunized with PTE IN or orally in microspheres, with or without added CT. In addition, culture of liver and tympanic bullae samples from these rabbits yielded growth of P. multocida less frequently compared to other P. multocida-challenged rabbits. Coadministration of CT and PTE did not significantly improve protective immunity to challenge.

摘要

口服微囊化抗原是一种给兔子接种疫苗以抵抗多杀性巴氏杆菌(一种常见的细菌病原体)的潜在方法。将五只兔子分为一组,在第0、7和14天经口给予不含添加蛋白的海藻酸盐微球、含有5mg多杀性巴氏杆菌硫氰酸钾提取物(PTE)的海藻酸盐微球或含有5mg PTE与200微克霍乱毒素(CT)的海藻酸盐微球。此外,给各实验组经口给予5mg可溶性PTE(含或不含200微克CT),经鼻内(IN)给予1mg可溶性PTE,或给予生理盐水。在初次免疫前以及10、16和21天后采集血清和鼻腔灌洗样本,通过酶联免疫吸附测定法(ELISA)检测抗PTE IgG和IgA。在用PTE经鼻内接种或掺入微球后经口免疫的兔子样本中发现了较强的鼻腔灌洗IgA和血清IgG活性。添加CT并未显著增强任何一种反应。为了检测保护性免疫的发展情况,各实验组以类似方式进行免疫,并在第16天经鼻内用10⁶CFU多杀性巴氏杆菌进行攻击暴露。一周后,对兔子实施安乐死,并对肺、鼻咽、肝脏和内耳的标本进行多杀性巴氏杆菌培养。在用PTE经鼻内接种或掺入微球经口免疫的兔子中,无论是否添加CT,肺和鼻咽的感染都较轻。此外,与其他受多杀性巴氏杆菌攻击的兔子相比,这些兔子的肝脏和鼓泡样本培养出多杀性巴氏杆菌的频率较低。CT与PTE共同给药并未显著提高对攻击的保护性免疫。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验